Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics

Jasper Therapeutics, Inc., (JSPR): $4.93

0.06 (+1.23%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add JSPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#289 of 301

in industry

JSPR Price/Volume Stats

Current price $4.93 52-week high $26.83
Prev. close $4.87 52-week low $3.13
Day low $4.86 Volume 215,300
Day high $5.09 Avg. volume 417,624
50-day MA $4.70 Dividend yield N/A
200-day MA $13.58 Market Cap 74.06M

JSPR Stock Price Chart Interactive Chart >


Jasper Therapeutics, Inc., (JSPR) Company Bio


Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.


JSPR Latest News Stream


Event/Time News Detail
Loading, please wait...

JSPR Latest Social Stream


Loading social stream, please wait...

View Full JSPR Social Stream

JSPR Price Returns

1-mo N/A
3-mo N/A
6-mo -76.17%
1-year -78.58%
3-year -84.35%
5-year N/A
YTD -76.94%
2024 170.98%
2023 63.39%
2022 -93.85%
2021 -21.58%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!